Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2015

Primary Completion Date

August 31, 2017

Conditions
Lymphoma
Interventions
DRUG

Lamivudine

"Creatinine Clearance (mL/min): ≥50, Recommended Dosage of Epivir: 150 mg twice daily or 300 mg once daily.~Creatinine Clearance (mL/min): 30-49, Recommended Dosage of Epivir: 150 mg once daily.~Subjects will be taking drug for 16 weeks."

DRUG

Tenofovir disoproxil fumarate

300 mg once a day p.o. for 16 weeks.

Trial Locations (1)

48109

University of Michigan Comprehensive Cancer Center, Ann Arbor

Sponsors
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Gilead Sciences

INDUSTRY

lead

University of Michigan Rogel Cancer Center

OTHER